Clinical Study To Assess The Efficacy of A Novel Hair Loss Treatment

Jamie Thomas Parker
{"title":"Clinical Study To Assess The Efficacy of A Novel Hair Loss Treatment","authors":"Jamie Thomas Parker","doi":"10.18034/mjmbr.v9i1.612","DOIUrl":null,"url":null,"abstract":"Background: Hair loss affects men and women around the world. \nObjective: This study analyzed the efficacy of a hair formula named Lotus 39 by Valentino De Salva (Lotus 39) on hair loss.  \nMethods: Men and women between ages 42 and 72 applied Lotus 39 to their scalp every day for 8 weeks. For ethical reasons, a nonrandomized controlled study protocol was selected \nResults: According to the data, Lotus 39 stops hair loss, causes an increase in vellus hair, and an increase total hair count.  \nLimitations:  No control was assigned due to funding, baseline pictures were taken at the onset of the study, during, and at the end of the study to draw a depiction of hair improvement over time. \nConclusion:   This study suggests that Lotus 39 improves the health of the scalp and hair. \n  \nIRB Approval Status: \nReviewed and approved by IntegReview IRB; approval #CRLNJ2019-0198","PeriodicalId":18105,"journal":{"name":"Malaysian Journal of Medical and Biological Research","volume":"37 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Malaysian Journal of Medical and Biological Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18034/mjmbr.v9i1.612","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Hair loss affects men and women around the world. Objective: This study analyzed the efficacy of a hair formula named Lotus 39 by Valentino De Salva (Lotus 39) on hair loss.  Methods: Men and women between ages 42 and 72 applied Lotus 39 to their scalp every day for 8 weeks. For ethical reasons, a nonrandomized controlled study protocol was selected Results: According to the data, Lotus 39 stops hair loss, causes an increase in vellus hair, and an increase total hair count.  Limitations:  No control was assigned due to funding, baseline pictures were taken at the onset of the study, during, and at the end of the study to draw a depiction of hair improvement over time. Conclusion:   This study suggests that Lotus 39 improves the health of the scalp and hair.   IRB Approval Status: Reviewed and approved by IntegReview IRB; approval #CRLNJ2019-0198
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
一种新的脱发治疗方法的临床研究
背景:脱发影响着全世界的男性和女性。目的:本研究分析Valentino De Salva命名为Lotus 39的护发配方(Lotus 39)对脱发的疗效。方法:年龄42 ~ 72岁的男性和女性每天将莲花39涂抹在头皮上,持续8周。出于伦理原因,我们选择了一项非随机对照研究方案。结果:根据数据,Lotus 39可以阻止脱发,导致毳毛增加,并增加毛发总数。限制:由于资金原因,没有分配对照,在研究开始时,研究期间和研究结束时拍摄基线照片,以描绘随时间推移的头发改善情况。结论:本研究提示荷花39能改善头皮和头发的健康。IRB审批情况:由IntegReview IRB审核通过;批准# crlnj2019 - 0198
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Recognizing Pearls and Pitfalls in The Emergency Medicine Department During Initiation of a New Stroke Thrombolysis Service The Impact of Reproductive Health on Female Victims of Violence by Partners A Paediatric Case of Severe Allergic Conjunctivits with Underlying Alopecia Areata Simultaneous Management of Unstable Angina and Renal Colic in Ankylosing Spondylitis Endothelial Cell Count and Central Corneal Thickness In Type-2 Diabetes
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1